Measuring B2C E-Commerce Activity
Your Speed May Vary
Sports Content Revenue Soars, Scores
Electronic Media and Entertainment Market (US)
Product Lifecycle Management (PLM) Software Market
ATM Statistics
Digital Cable Adoption Rises in North America
Communication Slowdown
Strategic Value Analysis for Competitive Advantage: An Illustration From the Petroleum Industry
Managers can do a far better job if they understand how each process they manage adds value. SVA is a tool for gaining that understanding.
Editor’s Note: this article will be most interesting to those who care about the oil & gas industry but the SVA concept seemed to me to be poorly elaborated and more useful as a hindsight analytical tool rather than a … [ Read more ]
Content: Article | Authors: Alfred Escher, Eric A. Spiegel, John K. Shank | Source: strategy+business | Subjects: Industry Specific, Strategy | Industry: Petro / Chemical
US Skiing Market
Net Not a Popular Outlet for Coupons
Expense Management Automation (EMA) Market
US Housing Industry Stats
Now, Dow?
How an irrelevant index survived the tech meltdown.
Editor’s Note: If you don’t know what the DJIA really is (or if you’re not sure), read this…it’s really interesting. For more instruction on the basics of market indices finance, visit
Content: Article | Author: Daniel Gross | Source: Slate | Subjects: Finance, Industry Specific | Industry: Investing
Zantac (A&B)
The anti-ulcer market is one of the largest categories of prescription drugs in the pharmaceutical industry. Its history dates to 1976, when a US based pharmaceutical company SmithKline launched Tagamet. This Nobel prize-winning breakthrough drug quickly rose to become the largest-selling pharmaceutical product. As the incumbent, Tagamet seemed unshakeable, but with the introduction of its ‘me-too’ product Zantac, UK-based Glaxo managed to … [ Read more ]
Content: Case Study | Authors: Christian Pinson, Reinhard Angelmar | Source: INSEAD | Subjects: Industry Specific, Marketing / Sales | Industry: Pharmaceutical | Company: GlaxoSmithKline plc
